These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 20032383)
21. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670 [TBL] [Abstract][Full Text] [Related]
22. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas. Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101 [TBL] [Abstract][Full Text] [Related]
23. Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation. Shibata MA; Akao Y; Shibata E; Nozawa Y; Ito T; Mishima S; Morimoto J; Otsuki Y Cancer Chemother Pharmacol; 2007 Oct; 60(5):681-91. PubMed ID: 17256131 [TBL] [Abstract][Full Text] [Related]
24. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Ray P; Tsien R; Gambhir SS Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415 [TBL] [Abstract][Full Text] [Related]
25. In vivo bioluminescence imaging. Sato A; Klaunberg B; Tolwani R Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260 [TBL] [Abstract][Full Text] [Related]
26. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
27. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model. Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752 [TBL] [Abstract][Full Text] [Related]
28. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012 [TBL] [Abstract][Full Text] [Related]
31. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Pulaski BA; Ostrand-Rosenberg S Cancer Res; 1998 Apr; 58(7):1486-93. PubMed ID: 9537252 [TBL] [Abstract][Full Text] [Related]
32. Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer. Madero-Visbal RA; Colon JF; Hernandez IC; Limaye A; Smith J; Lee CM; Arlen PA; Herrera L; Baker CH Surg Oncol; 2012 Mar; 21(1):23-9. PubMed ID: 20801643 [TBL] [Abstract][Full Text] [Related]
33. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. Smakman N; Martens A; Kranenburg O; Borel Rinkes IH J Surg Res; 2004 Dec; 122(2):225-30. PubMed ID: 15555622 [TBL] [Abstract][Full Text] [Related]
34. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768 [TBL] [Abstract][Full Text] [Related]
35. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372 [TBL] [Abstract][Full Text] [Related]
36. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oates AJ; Barraclough R; Rudland PS Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559 [TBL] [Abstract][Full Text] [Related]
37. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024 [TBL] [Abstract][Full Text] [Related]
38. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173 [TBL] [Abstract][Full Text] [Related]
39. Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model. Au JT; Gonzalez L; Chen CH; Serganova I; Fong Y Ann Surg Oncol; 2012 Sep; 19(9):3116-22. PubMed ID: 22466665 [TBL] [Abstract][Full Text] [Related]
40. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]